Therapy-Related Acute Myeloid Leukemia Mimicking Lymphoma: a Diagnostic Dilemma

被引：0
作者：
Zhang, Juanjuan [1 ]
Wang, Nan [1 ]
Guo, Ying [2 ]
Song, Huijuan [3 ]
Xu, Jing [4 ]
机构：
[1] Handan Peoples Hosp, Dept Clin Lab, Handan, Hebei, Peoples R China
[2] Univ Hebei, Affiliated Hosp Engn, Dept Sci & Educ, Baoding, Hebei, Peoples R China
[3] Dalian Univ, Affiliated Zhongshan Hosp, Dept Clin Lab, Dalian, Liaoning, Peoples R China
[4] Ganzhou Peoples Hosp, Dept Clin Lab, Ganzhou 341000, Jiangxi, Peoples R China
来源：
CLINICAL LABORATORY | 2022年 / 68卷 / 05期
关键词：
therapy-related leukemia; breast cancer; acute monocyt-ic leukemia; lymphoma; MYELODYSPLASTIC SYNDROME; BREAST-CANCER; CYCLOPHOSPHAMIDE;
D O I：
10.7754/Clin.Lab.2021.210744
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Background: Based on the 2017 revision of the World Health Organization Classification, therapy-related myeloid neoplasms consist of therapy-related acute myeloid leukemia, therapy-related myelodysplastic syndromes, and therapy-related myelodysplastic/myeloproliferative neoplasms, which exist as a late-occurring complication of radiation and/or chemotherapy treatment due to previous application of iatrogenic mutagenic agents. Methods: Here we present the first described case of therapy-related acute monocytic leukemia mimicking lymphoma after chemotherapy and radiotherapy for breast cancer. Results: Based on immunophenotypic analysis and biopsy of the BM, the patient was diagnosed with acute monocytic leukemia (AML FAB M5b) according to WHO classification. Due to short interval of development, a diagnosis of therapy-related acute monocytic leukemia was made. Conclusions: The atypical morphology of the patient, a diagnostic mistake, resulted in an initial diagnosis of secondary lymphoma. Recognizing the atypical morphology is vital in distinguishing it from lymphoma, which is closely related to the treatment and prognosis of the patient. (Clin. Lab. 2022;68:xx-xx. DOI: 10.7754/Clin.Lab.2021.210744)
引用
收藏
页码：2405 / 2408
页数：4
相关论文
共 9 条
  • [1] Aidan J Cole, 2013, Ulster Med J, V82, P97
  • [2] Arber DA, 2017, World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, V4th, P156
  • [3] Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy
    Linassier, C
    Barin, C
    Calais, G
    Letortorec, S
    Brémond, JL
    Delain, M
    Petit, A
    Georget, MT
    Cartron, G
    Raban, N
    Benboubker, L
    Leloup, R
    Binet, C
    Lamagnère, JP
    Colombat, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (10) : 1289 - 1294
  • [4] Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study
    Martin, Mike G.
    Welch, John S.
    Luo, Jingqin
    Ellis, Matthew J.
    Graubert, Timothy A.
    Walter, Matthew J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 593 - 598
  • [5] Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer
    Nichols, G
    de Castro, K
    Wei, LX
    Griffin, M
    Lin, N
    Oratzi, A
    Murty, VVVS
    Troxel, A
    Vahdat, L
    Hesdorffer, C
    [J]. LEUKEMIA, 2002, 16 (09) : 1673 - 1679
  • [6] Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide
    Praga, C
    Bergh, J
    Bliss, J
    Bonneterre, J
    Cesana, B
    Coombes, RC
    Fargeot, P
    Folin, A
    Fumoleau, P
    Giuliani, R
    Kerbrat, P
    Hery, M
    Nilsson, J
    Onida, F
    Piccart, M
    Shepherd, L
    Therasse, P
    Wils, J
    Rogers, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4179 - 4191
  • [7] THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8, 21), INV(16), AND T(8, 16) - A REPORT ON 25 CASES AND REVIEW OF THE LITERATURE
    QUESNEL, B
    KATARJIAN, H
    BJERGAARD, JP
    BRAULT, P
    ESTEY, E
    LAI, JL
    TILLY, H
    STOPPA, AM
    ARCHIMBAUD, E
    HAROUSSEAU, JL
    BAUTERS, F
    FENAUX, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) : 2370 - 2379
  • [8] Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: The national surgical adjuvant breast and bowel project experience
    Smith, RE
    Bryant, J
    DeCillis, A
    Anderson, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1195 - 1204
  • [9] Vardiman JW., 2017, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, VRev. 4th ed., P153
1